$0.91 -0.05 (-5.53%) Bioline RX Shs Sponsored American Deposit Receipt Repr 1 Sh - NASDAQ

Aug. 25, 2016 | 03:50 PM
Last Trade: 0.91
Trade Time: Aug 25 03:50 PM Eastern Daylight Time
Change: -0.05 (-5.53%)
Prev Close: 0.96
Open: 1.00
Bid: 0.91
Ask: 0.92
  1. No results found.
  1. BioLineRx Receives Confirmation of Medical Device Classification in Europe for Celiac Treatment

    Benzinga | Jan. 25, 2016 | 07:01AM EST
  2. Merck, BioLineRx teaming up

    IBD | Jan. 12, 2016 | 18:40PM EST
  3. Earnings Scheduled For November 16, 2015

    Benzinga | Nov. 16, 2015 | 04:01AM EST
  4. BioLineRx to Present at the 17th Annual Rodman & Renshaw Global Investment Conference in New York

    Benzinga | Sep. 3, 2015 | 07:04AM EST
  5. Market Update: Monday's Mid-Day Movers, China's Stock Market Crash And More

    Benzinga | Jul. 27, 2015 | 12:36PM EST
  6. Morning Market Losers

    Benzinga | Jul. 27, 2015 | 09:50AM EST
  7. Benzinga's Top Initiations

    Benzinga | Jun. 22, 2015 | 09:27AM EST
  8. JP Morgan Initiates Bioline RX With Market Outperform

    Benzinga | Jun. 22, 2015 | 07:11AM EST
  9. BioLineRx Says Will Present Successful Results of Phase 1/2 Study of Novel Celiac Treatment

    Benzinga | Jun. 17, 2015 | 07:01AM EST
  10. Research Underlying BioLineRx's Treatment of Type 1 Diabetes Wins Hebrew University's Kaye Innovation Award

    Benzinga | Jun. 3, 2015 | 07:00AM EST
  11. BioLineRx Reports Peer-Reviewed Publication of Phase 1/2 Trial Results for Novel Treatment for Non-Surgical Removal of Skin Lesions

    Benzinga | Jun. 1, 2015 | 07:04AM EST
  12. BioLineRx Announces Will Present Safety, Efficacy Clinical Data for Novel Stem Cell Mobilization Treatment at EHA

    Benzinga | May. 27, 2015 | 07:23AM EST
  13. Earnings Scheduled For May 18, 2015

    Benzinga | May. 18, 2015 | 04:05AM EST
  14. Morning Market Movers

    Benzinga | Dec. 16, 2014 | 09:42AM EST
  15. Benzinga's Top #PreMarket Gainers

    Benzinga | Dec. 16, 2014 | 08:05AM EST
Trading Center